Literature DB >> 9642703

Follow-up of intertrochanteric osteotomy of the hip during a 25-year period.

B J McGrory1, D M Estok, W H Harris.   

Abstract

In 1984, in reporting follow-up on 67 hips in 61 patients who underwent intertrochanteric osteotomies for osteoarthritis of the hip, we found that between 12 and 15 years after osteotomy, 34% (23) of the 67 hips remained functional and the remainder had been converted to an arthroplasty. We now report on the fate of those osteotomies over a 25-year period. Ten patients with 10 osteotomies did not require an arthroplasty, having died without requiring conversion to total hip arthroplasty at an average of 18.3 years after osteotomy (range: 11 to 24.1 years). Two others were living at an average of 25.2 years after osteotomy without requiring conversion. Thus, for 18% of the hips, no further hip surgery was performed. For the remaining 55 hips in 49 patients, the osteotomy had served for an average of 9.8 years (range: 1.3 to 26.1 years) before requiring arthroplasty. The cumulative probability of osteotomy survival was 57.8% (standard error: 6.0%) at 10 years, 20.0% (standard error: 4.9%) at 20 years, and 5.7% (standard error: 2.9%) at 25 years by Kaplan-Meier survivorship analysis.

Entities:  

Mesh:

Year:  1998        PMID: 9642703     DOI: 10.3928/0147-7447-19980601-07

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  3 in total

1.  [Hip resurfacing arthroplasty].

Authors:  W-C Witzleb; A Knecht; T Beichler; T Köhler; K-P Günther
Journal:  Orthopade       Date:  2004-11       Impact factor: 1.087

2.  Long-term results of cementless femoral reconstruction following intertrochanteric osteotomy.

Authors:  Christian Merle; Marcus R Streit; Moritz Innmann; Tobias Gotterbarm; Peter R Aldinger
Journal:  Int Orthop       Date:  2012-01-12       Impact factor: 3.075

3.  Long-term results of intertrochanteric varus osteotomy for dysplastic osteoarthritis of the hip.

Authors:  Jochen Zweifel; Wolfgang Hönle; Alexander Schuh
Journal:  Int Orthop       Date:  2009-09-12       Impact factor: 3.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.